Literature DB >> 15569967

Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials.

Debbie A Lawlor1, George Davey Smith, Shah Ebrahim.   

Abstract

OBJECTIVES: We assessed the association between life-course socioeconomic status or position (SEP) and hormone replacement therapy (HRT).
METHODS: We conducted a cross-sectional analysis of 4286 women aged 60 to 79 years.
RESULTS: Women experiencing adverse socioeconomic circumstances across the life course were less likely to have used HRT. The associations of childhood socioeconomic measures with HRT use were independent of adult SEP, behavioral risk factors, and physiological risk factors for heart disease.
CONCLUSIONS: SEP from across the life course is associated with HRT use. Because the association between early life SEP and HRT is not fully explained by adult risk factors, residual confounding (which is not captured by adjustment for adult variables only) may explain some of the disparity between observational studies and randomized controlled trials in this area.

Entities:  

Mesh:

Year:  2004        PMID: 15569967      PMCID: PMC1448605          DOI: 10.2105/ajph.94.12.2149

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  26 in total

1.  Social and behavioural influences on the uptake of hormone replacement therapy among younger women.

Authors:  D Kuh; R Hardy; M Wadsworth
Journal:  BJOG       Date:  2000-06       Impact factor: 6.531

2.  Can the "specificity" of an association be rehabilitated as a basis for supporting a causal hypothesis?

Authors:  Noel S Weiss
Journal:  Epidemiology       Date:  2002-01       Impact factor: 4.822

3.  Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Am J Epidemiol       Date:  2002-01-15       Impact factor: 4.897

4.  Hormone replacement therapy in epidemiologic studies and randomized clinical trials - are we checkmate?

Authors:  Karin B Michels
Journal:  Epidemiology       Date:  2003-01       Impact factor: 4.822

5.  Larger lessons from the Women's Health Initiative.

Authors:  Steven Piantadosi
Journal:  Epidemiology       Date:  2003-01       Impact factor: 4.822

6.  Data dredging, bias, or confounding.

Authors:  George Davey Smith; Shah Ebrahim
Journal:  BMJ       Date:  2002-12-21

7.  Socioeconomic position in childhood and adulthood and insulin resistance: cross sectional survey using data from British women's heart and health study.

Authors:  Debbie A Lawlor; Shah Ebrahim; George Davey Smith
Journal:  BMJ       Date:  2002-10-12

8.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

9.  Impact of childhood and adulthood socioeconomic position on cause specific mortality: the Oslo Mortality Study.

Authors:  B Claussen; G Davey Smith; D Thelle
Journal:  J Epidemiol Community Health       Date:  2003-01       Impact factor: 3.710

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  17 in total

Review 1.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

2.  Evaluating the effectiveness of a rapidly adopted cardiovascular technology with administrative data: the case of drug-eluting stents for acute coronary syndromes.

Authors:  Jerome J Federspiel; Sally C Stearns; Brett C Sheridan; Jack J Kuritzky; Laura P D'Arcy; Daniel J Crespin; Timothy S Carey; Joseph S Rossi
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

3.  Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  Menopausal hormone therapy and sleep-disordered breathing: evidence for a healthy user bias.

Authors:  Anna G Mirer; Paul E Peppard; Mari Palta; Ruth M Benca; Amanda Rasmuson; Terry Young
Journal:  Ann Epidemiol       Date:  2015-08-06       Impact factor: 3.797

Review 5.  Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.

Authors:  Sánchez R Gabriel; L Carmona; M Roque; Gómez L M Sánchez; X Bonfill
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  Accuracy of adults' recall of childhood social class: findings from the Aberdeen children of the 1950s study.

Authors:  G David Batty; Debbie A Lawlor; Sally Macintyre; Heather Clark; David A Leon
Journal:  J Epidemiol Community Health       Date:  2005-10       Impact factor: 3.710

Review 7.  Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

Authors:  Jacqueline O'Brien; John W Jackson; Francine Grodstein; Deborah Blacker; Jennifer Weuve
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

8.  Adverse socioeconomic position across the lifecourse increases coronary heart disease risk cumulatively: findings from the British women's heart and health study.

Authors:  Debbie A Lawlor; Shah Ebrahim; George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

9.  Family socioeconomic position at birth and future cardiovascular disease risk: findings from the Aberdeen Children of the 1950s cohort study.

Authors:  Debbie A Lawlor; Georgina Ronalds; Sally Macintyre; Heather Clark; David A Leon
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

10.  Indicators of socioeconomic position (part 1).

Authors:  Bruna Galobardes; Mary Shaw; Debbie A Lawlor; John W Lynch; George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.